Randomized Study of Abemaciclib Combined with Standard Adj Endocrine Therapy vs Standard Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, HR+, HER2 Neg, Breast Cancer (B58)
Randomized Study of Abemaciclib Combined with Standard Adj Endocrine Therapy vs Standard Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, HR+, HER2 Neg, Breast Cancer (B58)
Trial Category:
Breast
Phase
III
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
Nebraska Hematology Oncology, Lincoln, NE
Southeast Nebraska Cancer Center, Lincoln, NE
